J2151 Mannitol Injection HCPCS Reimbursement

HCPCS Level II code J2151 denotes the injection of mannitol, 250 mg, a hyperosmotic agent used in acute care to reduce intracranial pressure and promote diuresis. Nationally, this code captures administration of a hospital- or emergency-based medication that is relevant for neurologic, neurosurgical, and critical care workflows and billing. Proper coding of J2151 affects hospital drug cost tracking, payer adjudication, and clinical documentation for acute therapeutic interventions.

Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for mannitol injection, typical sites of service where J2151 is used, and what to expect in payer coverage patterns in general terms. The publication summarizes national benchmarks and common billing practices, highlights recent policy updates that affect HCPCS drug administration coding, and outlines documentation elements commonly reviewed by payers.

This summary equips billing managers, clinical coders, and revenue professionals with the essential context to identify when J2151 applies, what service settings most frequently use it, and where to look for payer-specific guidance. Data not available in the input is noted in the detailed sections.

Billing Code Overview

HCPCS Level II code J2151 describes an injection of mannitol, 250 mg. This code represents a medication administration service for a hyperosmotic agent commonly used in clinical settings to reduce intracranial pressure or to promote diuresis in specific indications.

Service Type: Drug administration (injection)

Typical Site of Service: Hospital inpatient, hospital outpatient, emergency department, or other acute care settings where intravenous infusions or injections are provided.

Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and detailed service line.

Clinical Context

A typical patient receiving J2151 (injection, mannitol, 250 mg) is an adult or pediatric inpatient or emergency department patient with acute intracranial hypertension or cerebral edema requiring osmotic therapy. Example scenario: a 46-year-old man presents to the emergency department after a traumatic brain injury with rapidly rising intracranial pressure (ICP) documented by neurosurgery. After initial stabilization, the neurosurgeon orders intravenous mannitol for rapid osmotic reduction of cerebral edema. The medication is prepared by pharmacy in an appropriate concentration and delivered to the floor or operating room. Administration occurs via an existing peripheral or central intravenous access by an RN with continuous monitoring of neurologic status, serum osmolarity, electrolytes, and urine output. Typical workflow steps: medication order by provider, pharmacy verification and preparation, nursing verification of indications and IV access, baseline labs (serum sodium, osmolarity, creatinine), slow bolus IV administration as directed, monitoring for hemodynamic changes and urine output, post-administration labs and documentation of response. Typical sites of service include the emergency department, inpatient hospital ward, intensive care unit, and operating room.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier	Standard reporting when no modifier applies

Taxonomy Code	Specialty	Notes
`2084P0800X`	Neurological Surgery	Neurosurgeons commonly order/administer mannitol perioperatively for elevated ICP
`363L00000X`	Critical Care Medicine	Intensivists manage osmotherapy in ICU patients with cerebral edema
`207RH0000X`	Emergency Medicine	Emergency physicians frequently initiate mannitol for acute intracranial hypertension
`334S00000X`	Hospital Pharmacy	Pharmacists compound/verify mannitol dosing and IV preparation
`363A00000X`	Anesthesiology	Anesthesiologists may administer mannitol intraoperatively for brain relaxation

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`G93.6`	Cerebral edema	Direct indication for osmotherapy with mannitol to reduce intracranial pressure
`S06.5X0A`	Traumatic subdural hemorrhage without loss of consciousness, initial encounter	Intracranial hemorrhage with mass effect may precipitate elevated ICP treated with mannitol
`S06.2X0A`	Diffuse traumatic brain injury without loss of consciousness, initial encounter	Severe traumatic brain injury often requires ICP control including mannitol
`I62.9`	Nontraumatic intracranial hemorrhage, unspecified	Spontaneous intracranial bleeding causing cerebral edema managed with osmotic agents
`G93.2`	Benign intracranial hypertension	Elevated intracranial pressure states where osmotherapy may be used in selected cases

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	May be used if facility reports an injectable medication administration service when appropriate for single-drug IV push administration workflows (note: hospital inpatient drug billing typically separate)
`96413`	Chemotherapy administration, intravenous infusion technique; hormonal, other than chemotherapy, up to 1 hour	May be used in outpatient infusion settings when reporting infusion services for intravenous medications administered over time
`43760`	Insertion of intracranial pressure monitor	Often performed in patients requiring mannitol for ICP monitoring and management
`61520`	Craniectomy, decompressive (hemicraniectomy) for trauma — unilateral	Surgical procedure that can be temporally associated with mannitol administration for cerebral edema control
`99195`	Moderate sedation services provided by the same physician performing a procedure	May be applicable when sedation is provided during procedures in which mannitol is used intraoperatively

OpenPayer

Summary & Overview

HCPCS J2151: Injection, Mannitol, 250 mg